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Abstract
The cationic β-sheet cyclic tetradecapeptide cyclo[VKLdKVdYPLKVKLdYP] (GS14dK4) is a diastereomeric lysine ring-size analog of the
potent naturally occurring antimicrobial peptide gramicidin S (GS) which exhibits enhanced antimicrobial but markedly reduced hemolytic activity
compared to GS itself. We have previously studied the binding of GS14dK4 to various phospholipid bilayer model membranes using isothermal
titration calorimetry [Abraham, T. et al. (2005) Biochemistry 44, 2103–2112]. In the present study, we compare the ability of GS14dK4 to bind to and
disrupt these same phospholipid model membranes by employing a fluorescent dye leakage assay to determine the ability of this peptide to
permeabilize large unilamellar vesicles. We find that in general, the ability of GS14dK4 to bind to and to permeabilize phospholipid bilayers of
different compositions are not well correlated. In particular, the binding affinity of GS14dK4 varies markedly with the charge and to some extent with
the polar headgroup structure of the phospholipid andwith the cholesterol content of themodel membrane. Specifically, this peptide bindsmuchmore
tightly to anionic than to zwitterionic phospholipids and much less tightly to cholesterol-containing than to cholesterol-free model membranes. In
addition, the maximum extent of binding of GS14dK4 can also vary considerably with phospholipid composition in a parallel fashion. In contrast, the
ability of this peptide to permeabilize phospholipid vesicles is only weakly dependent on phospholipid charge, polar headgroup structure or
cholesterol content. We provide tentative explanations for the observed lack of a correlation between the affinity and extent of GS14dK4 binding to,
and degree of disruption of the structure and integrity of, phospholipid bilayers membranes. We also present evidence that the lack of correlation
between these two parameters may be a general phenomenon among antimicrobial peptides. Finally, we demonstrate that the affinity of binding of
GS14dK4 to various phospholipid bilayer membranes is muchmore strongly correlated with the antimicrobial and hemolytic activities of this peptide
than with its effect on the rate and extent of dye leakage in these model membrane systems.
© 2007 Elsevier B.V. All rights reserved.Keywords: Gramicidin S; Antimicrobial peptide; Phospholipid bilayer; Phospholipid membrane; Lipid–peptide interaction; Peptide binding; Membrane
permeabilization; Isothermal titration calorimetry; Dye leakageAbbreviations: AMP, antimicrobial peptide; GS, Gramicidin S, cyclo[VOLdFPVOLdFP] (the amino acid immediately after d is the D-enantiomer); GS10, cyclo
[VKLdYPVKLdYP]; GS14, gramicidin analogue, cyclo[VKLKVdYPLKVKLdYP]; GS14dK4, gramicidin analogue, cyclo[VKLdKVdYPLKVKLdYP]; POPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphorylcholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(glycerol)] (sodium salt); POPS, 1-palmitoyl-2-oleoyl-
sn-glycero-3-[phosphoserine] (sodium salt); ITC, isothermal titration calorimetry; LUV, large unilamellar vesicle; Kc, equilibrium binding constant; Bmax, degree of
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The chemical structure, physical properties and mechanism
of action of antimicrobial peptides (AMPs1) have been the focus
of considerable fundamental and applied research interest in
recent years. These peptides are produced by a number of
microorganisms and are widely distributed in animals and
plants, where they form part of the innate immune defense
mechanism of the host species [1–5]. AMPs exist in wide variety
of structural motifs (α-helical, β-sheet, linear and cyclic, see
[6,7]) but almost all are cationic amphiphilic molecules which
can interact with the bacterial inner membrane, the lipid bilayer
of which appears to be their primary target. The mode of action
of most AMPs is thought to involve an initial electrostatic
interaction between anionic phospholipids in the outer mono-
layer of the bacterial membrane and the cationic amino acid
residues of the peptide, followed by partial penetration of the
peptide into the lipid bilayer, thus allowing the hydrophobic
amino acid residues of the peptide to interact with the
hydrocarbon chains of the phospholipids. Most of these peptides
are believed to kill bacteria by compromising the structural and
functional integrity of the phospholipid bilayer of the target
membrane [1–6]. AMPs are currently being investigated as
potential source of novel therapeutic antibiotics to combat the
increasing numbers of microorganisms which are resistant to
conventional antibiotics [1–5].
The antimicrobial peptide GS, first isolated from the Gram-
positive bacterium Bacillus brevis (7), is one of a series of AMPs
produced by this organism [8,9]. GS is a cyclic cationic decamer
(primary structure cyclo[VOLdFPVOLdFP]) in which the two
tripeptide sequences Val–Orn–Leu form antiparallel β-sheets
terminated on each side by a type II′ β-turn formed by the two D-
Phe-Pro sequences. GS thus exists as fairly rigid amphipathic
structure in which the two polar positively charged Orn side
chains project from one side and the four hydrophobic Leu and
Val side chains project from the other side. This structure is
stabilized by cross-ring intramolecular hydrogen bonds invol-
ving the amide protons and carbonyl groups of the two Leu and
two Val residues [8,9]. GS is a powerful antibiotic against a
broad range of Gram-negative and Gram-positive bacteria as
well as against several pathogenic fungi [8,9]. However, GS is
also highly hemolytic and thus its therapeutic use is restricted to
topical applications [7–9]. A large number of structure-activity
studies of GS analogs have shown that the expression of
antibiotic activity is contingent upon the retention of a β-sheet
conformation in which cationic and hydrophobic side chains are
segregated on opposite faces of the molecule [9,10].
A substantial body of evidence exists that the major target of
GS is the lipid bilayer of bacterial or erythrocyte membranes and
that this peptide kills bacterial cells and lyses erythrocytes by
permeabilizing and destabilizing their cytoplasmic membranes
[1,9,10]. In order to determine the molecular mechanism of
action of GS, we have recently carried out a number of bio-
physical studies of its interactions with a variety of lipid bilayer
model membranes [10]. In particular, we have shown by DSC
that GS more strongly perturbs the thermotropic phase behavior
of anionic as compared to zwitterionic phospholipid bilayers andof more fluid as compared to less fluid membranes [11], and we
have demonstrated by densitometry and sound velocity studies
that GS incorporation decreases the density and volume
compressibility of the host phospholipid bilayer by increasing
the conformational disorder and motional freedom of the
phospholipid hydrocarbon chains [12]. Our 31P-NMR [13] and
X-ray diffraction [14] studies indicate that at low concentrations,
GS causes the thinning of phospholipid bilayers and can induce
the formation of inverted nonlamellar cubic phases in phospho-
lipid dispersions at higher peptide concentrations. Our FTIR
studies show that GS is located in the polar/apolar interfacial
region of phospholipid bilayers and that it penetrates more
deeply into anionic and more fluid bilayers as compared to
zwitterionic and less fluid membranes [15]. As well, several
physical techniques indicate that the presence of cholesterol
attenuates all of the above effects of GS on phospholipid bi-
layers, at least in part by reducing the penetration of this peptide
into these model membranes [15,16]. Finally, our solid-state 19F-
NMR study of a 19F-labeled GS analog suggests that the GS
molecule is aligned with its cyclic β-sheet lying flat in the plane
of the bilayer, with its polar and positively charged Orn residues
projecting toward the bilayer surface, where they can interact
with negatively charged phosphate headgroups of the phospho-
lipid molecules, while the four hydrophobic Val and Leu re-
sidues project toward the bilayer center, where they interact with
the phospholipid hydrocarbon chains [17].
We have recently shown that strongly antimicrobial GS
analogs with markedly reduced hemolytic activity can be
obtained by simultaneously altering both ring size and the en-
antiomeric conformation of key amino acid residues [18–22],
thus opening the way for the possible development of further GS
analogs for use as potent oral or injectable broad-spectrum
antibiotics [23]. GS14dK4 is a particularly promising candidate
in this regard because of its comparable antimicrobial activity to
that of GS and its substantially lower hemolytic activity [19–23].
This analog consists of two antiparallel β-sheets with aligned
sequences of alternating hydrophobic and cationic residues,
Val–Lys–Leu–dLys–Val and Val–Lys–Val–Lys–Leu, con-
nected at each end of the ring by the dipeptide sequence dTyr–
Pro. Thus, it is a diastereomeric analogue of GS14 in which the
L-lysine at position 4 is substituted by D-lysine. In the parent
compound, GS14, all four lysine units project to the one
hydrophilic face of the ring, while in GS14dK4, the Lys-4
projects partially to the hydrophobic face of the molecule [24].
This makes GS14dK4 relatively more water soluble, less
amphiphilic, and less susceptible to dimerization than GS14
itself [24].
The interaction between GS14dK4 and lipid bilayer model
membranes has been studied in an effort to understand the basis
of its capacity to more strongly differentiate between bacterial
and mammalian cell membranes [25]. We find that GS14dK4,
like GS, interacts more strongly with anionic lipid bilayers than
with zwitterionic, uncharged, or cationic lipid model membranes
[16]. However, the interaction of GS14dK4 with such model
membranes is generally weaker than with GS and depends more
strongly on the charge of the bilayers. Moreover, GS14dK4, like
GS, interacts more strongly with liquid crystalline than with gel-
Table 1
Binding parameters for the binding of GS14dK4 to various LUVs
Systems Bmax mol/mol Kc [M]
−1
POPC ∼0.006 3.6×103
POPG 0.20 4.6×106
POPS 0.19 1.6×106
POPC:POPG (3:1) 0.09 3.2×105
POPC:POPS (3:1) 0.07 5.9×105
POPC:cholesterol (3:2) No measurable binding
POPG:cholesterol (3:2) 0.10 6.3×105
POPS:cholesterol (3:2) 0.11 3.3×104
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pletely excluded from cholesterol-rich zwitterionic lipid mem-
branes, whereas cholesterol only attenuates the interactions of
GS with such lipid bilayers [16]. GS14dK4, despite its ap-
parently weaker interactions with phospholipid membranes, is
also more effective in permeabilizing cholesterol-free lipid
membranes than GS [25]. These observations suggest that
GS14dK4 retains the ability to disrupt bacterial membranes as
effectively as GS because of its innately greater ability to
disrupt lipid bilayers and its retained selectivity for binding to
anionic lipids, but exhibits much weaker hemolytic activity
because of its exclusion from cholesterol-containing zwitter-
ionic lipid membranes.
The AMP-induced leakage of fluorescent dyes entrapped in
LUVs of different phospholipid and cholesterol compositions is
a widely used method for assessing the relative potency of these
peptides for disrupting the integrity of lipid bilayer membranes
and thus for predicting their antimicrobial and hemolytic
activities [1–5]. However, whether or not conventional dye
leakage assays are a valid proxy for AMP-induced phospholipid
bilayer disruption and antimicrobial and hemolytic activity
remains unclear. In order to address this question, we compare
here the ability of GS14dK4 to induce calcein dye leakage from
LUVs composed of a variety of zwitterionic and anionic
phospholipids, containing or not containing cholesterol, with the
strength and extent of GS14dK4 binding to these same model
membrane systems, as previously determined by ITC [26].
Surprisingly, the dye leakage results do not correlate well with
either the results obtained by ITC or with the antibacterial or
hemolytic activity of this peptide, nor with previous biophysical
studies of the ability of GS14dK4 to disorder phospholipid bi-
layer membranes.
2. Materials and methods
2.1. Materials
All phospholipids and cholesterol were obtained from Avanti Polar Lipids
Inc. (Alabaster, AL, USA) and used without further purification. Calcein was
supplied by Molecular Probes (Eugene, OR, USA). The linear peptide sequence
VKLdKVdYPLKVKLdYP was synthesized by solid-phase peptide synthesis
using t-butyloxycarbonyl chemistry. The linear peptide was then N- to C- (Pro at
the C-terminus) terminally cyclized in solution to produce GS14dK4 [19,20].
Both the linear and cyclic peptides were purified and analyzed by RP-HPLC and
mass spectrometry to a final purity of N95%. The concentration of the pure
peptides in aqueous stock solutionswas determined by amino acid analysis with a
range of error of ±5%. All experiments, unless otherwise stated, were
conducted in a buffer solution containing 50 mM Tris, 150 mM NaCl and
1 mM NaN3, pH 7.4.
2.2. Preparation of dye-encapsulated LUVs and assay of dye leakage
In a typical experiment, a defined amount of lipid was first dried under
reduced pressure (vacuum) overnight. Calcein was dissolved in the same Tris
buffer used at self-quenching concentrations (70 mM). Dried lipid was hydrated
with the calcein-containing Tris buffer. After 4 or 5 freeze–thaw cycles, large
unilamellar vesicles (LUVs) were prepared by extrusion through 200 nm filters
(extruder and filters were obtained from Avestin, Ottawa, Ontario, Canada).
Excess dye was removed on pre-packed columns of PD-10 containing Sephadex
G-25M (Amersham Pharmacia, Quebec, Canada) and the lipid content
determined by gas–liquid chromatography using an appropriate internal standard(±5% error). Calcein leakage experimentswere recordedwith a Perkin Elmer LS-
50B spectrofluorimeter (Beaconsfield, UK). The excitation wavelength was
496 nm, the emission was 517 nm and slit widths of 5 nm were used. The
temperature (25 °C) was controlled by an external water bath (Neslab,
Portsmouth, NH, USA). Dye leakage experiments were performed in both the
continuous recording and batch mode. In the continuous-recording mode,
baseline fluorescence was recorded from 3-ml aliquots of buffer containing
calcein dye entrapped in LUVs. Subsequently, peptide was added with very rapid
mixing and the fluorescence of the mixture was continuously recorded until the
emission levels stabilized (typically 10–15 min). Finally, 100 μl of 1% Triton-
X100 was added to lyse the vesicles completely, so that dye release com-
mensurate with total leakage could be recorded. Typically, continuous recording
assays were performed at phospholipid concentrations of 25 μM. However, in
experiments designed to measure the kinetics of dye release, a higher signal
intensity was required to ensure greater accuracy of measurement, and it was also
necessary to reduce the absolute rates of dye leakage to effect a more accurate
recording of the kinetics and to improve the resolution between the rates of dye
leakage from the different types of lipid vesicles used. This was achieved by
increasing phospholipid concentrations to values near 50–60 μM. In the batch
mode measurements, 100 μl aliquots of peptide- (or Triton-X100) containing
buffer were equilibriated in a 96-well plate reader at 25 °C for 10–15 min and
25 μl of a dispersion of LUVs containing entrapped calcein dye were added to
obtain a total lipid concentration of 25 μM. Subsequently, the mixture was
incubated at 25 °C for 30 minutes, after which the fluorescence emission of each
mixturewere recordedwith the aid of a plate reader attachment. The results of our
continuous recording assays (for examples, see below) indicate that the
incubation time of 30 min was sufficient to ensure the completion of peptide-
induced dye leakage under all conditions examined. Typically, the continuous
recording assays were performed to examine aspects of the kinetics of the dye
leakage process and, primarily for conservation reasons, batch assays were
typically performed to measure apparent LD50 values for the dye leakage
process. In both cases, the percentage leakage was calculated as follows: %
leakage=(FP−F0)×100 / (FT−F0), where F0 and FP denote the fluorescence
intensity before and after peptide addition, and FT denotes the fluorescence
intensity after the addition of 1% (w/v) Triton X-100, which completely lysed the
LUVs and released all of the entrapped fluorescent dye. The same procedures
were followed for two-component vesicles, except that appropriate quantities of
each component (lipid and cholesterol) were first co-dissolved in chloroform,
thoroughly mixed and dried prior to vesicle preparation. In cases where duplicate
experiments yielded closely similar results, both dye assays were performed
twice; otherwise, the dye leakages assays were performed three or four times.3. Results
We have previously investigated the binding of GS14dK4 to
a variety of lipid bilayer model membranes by ITC [26] and a
summary of the results obtained is presented in Table 1. In
particular, the binding of this peptide to single-component
LUVs composed of the zwitterionic phospholipid POPC and the
anionic phospholipids POPG and POPS, and to two-component
LUVs composed of POPC and either POPG or POPS, was
Fig. 1. Continuous-recording traces illustrating GS14dK4-induced calcein
leakage from POPC vesicles at 25 °C. The data shown were acquired as a
function of time at the peptide concentrations indicated. For each trace the
asterisks mark time at which the peptide was added and the arrows mark the time
at which total leakage was induced by the addition of Triton-X100.
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and charge on GS14dK4 binding. As well, peptide binding to
two-component LUVs composed of either POPC, POPG or
POPS and cholesterol was examined in order to investigate the
effects of alterations in membrane lipid order and fluidity on
GS14dK4 binding. We review the results of these ITC studies
briefly below, so that the reader may compare them to the
fluorescence dye leakage results to be presented immediately
thereafter, which were performed on various LUVs having
exactly the same phospholipid and cholesterol compositions. In
the following summary, we concentrate on two key parameters,
Kc and Bmax, which represent the affinity and maximum extent
of binding, respectively, of this peptide to the various phospho-
lipid bilayer model membrane systems studied.
The data in Table 1 indicate clearly that the binding affinity
of GS14dK4 to various single-component LUVs varies
markedly. In particular, the Kc value for peptide binding to
POPC LUVs is about 1000-fold higher than that for POPG and
POPS LUVs, indicating that GS14dK4 binds anionic phos-
pholipid bilayers with a much higher affinity than zwitterionic
phospholipid bilayers, but also binds about 3-fold more tightly
to anionic POPS than to anionic POPG bilayers. Similarly, the
maximum extent of binding, as reflected in the Bmax values, is
also about 30-fold higher in the anionic POPG and POPS than
in the zwitterionic POPC LUVs. Moreover, the Kc and Bmax
values for the two-component POPC:POPG and POPC:POPS
LUVs are intermediate between those of the zwitterionic
POPC and anionic POPG and POPS LUVs, as expected. Thus,
the ITC data presented in Table 1 indicate that GS14dK14
binding to phospholipid bilayer model membranes is very
strongly dependent on the surface charge of the bilayer and
much less strongly dependent on the structure of the polar
headgroup of the phospholipid. The ITC data in Table 1 also
indicate that the incorporation of cholesterol into either
zwitterionic POPC or anionic POPG or POPS bilayers
markedly increases the Kc and modestly decreases the Bmax
values for peptide binding. This result indicates that the
presence of cholesterol decreases both the strength and extent
of GS14dK4 binding to both zwitterionic and anionic
phospholipid bilayers, as we have also reported for GS itself
[28] and for GS10 [20], the parent compound of GS14dK4. As
previously, we ascribe this reduced strength and extent of
peptide binding to cholesterol-containing LUVs to the increase
in phospholipid organization and packing induced by the
incorporation of cholesterol into phospholipid bilayer mem-
branes above their gel/liquid–crystalline phase transition
temperatures (see references [26,27] for a more detailed
thermodynamic analyses of peptide binding).
The ability of GS14dK4 to permeabilize phospholipids bi-
layers was investigated by an examination of their capacity to
release calcein entrapped in LUVs of various phospholipid and
cholesterol compositions, in an effort to correlate the GS14dK4
model membrane binding data (Table 1) with model membrane
disruption. These studies were performed at 25 °C as were our
ITC studies reported earlier [26]. As illustrated in Fig. 1, the
addition of dye-containing LUVs to a GS14dK4 solution
induced dye release, reflected in a fluorescence increase due torelease from a self-quenching environment upon dye dilution
into the aqueous medium. As expected, the rate and extent of
peptide-induced dye leakage increases with the total peptide
concentration in the GS14dK4 solution. Interestingly, however,
the kinetics of the last phase of the dye leakage process (the
initial phase was not measurable with the equipment at our
disposal) was definable in terms of a single time constant, the
magnitude of which varied significantly with peptide concen-
tration and the composition of the liposomes targeted. For
example, with POPC liposomes, the apparent time constant for
the later stages of the process is less than 5 s at peptide
concentrations near 10 μM and approaches values near 300 s at
peptide concentrations near 0.1 μM, whereas with POPG
vesicles, the apparent time constants approaches values near
7.3 s at 2 μM GS14dK4 and is essentially immeasurable at
higher concentrations.
A comparison of the apparent time constants measured under
comparable conditions for the various lipid systems examined is
presented in Table 2. The data show that the apparent time
constants for dye leakage from zwitterionic POPC LUVs are
about two- to four-fold greater than those obtained with the
anionic LUVs, POPG and POPS, indicating that GS14dK4-
induced dye release from anionic vesicles is considerably faster
than from zwitterionic phospholipids. Also, the time constants
measured for the calcein release from LUVs composed of
mixtures of zwitterionic and anionic phospholipids are in
between those measured for the individual components, con-
sistent with the idea that membrane surface charge density is a
significant factor in the dye release process. The data also indicate
that the magnitude of the apparent time constant for dye release
from POPC LUVs is about 6-fold smaller than from POPC:
cholesterol LUVs, indicating that the presence of cholesterol in
zwitterionic phospholipid bilayers markedly decreases the rate of
dye release. This observation is also compatiblewith the results of
our ITC and FTIR spectroscopic studies [24,26], which both
Fig. 2. GS14dK4-induced calcein leakage from single-component and two-
component lipid vesicles. Leakage data are presented as a function of peptide
concentration after incubation for 30 min at 25 °C. POPC:POPG (3:1)—▪—;
POPC:POPS (3:1)┄▴┄; POPC —□—; POPG —○—; POPS┄△┄.
Table 2
Parameters defining GS14dK4-induced calcein leakage from 200 nm LUVS
Lipid composition ∗Time constant
[2 μM Peptide]
LD50 vs.
Peptide-inducible
maximum
LD50 vs.
Triton
X-100
∗Peptide-inducible
dye release
(% maximal)
POPC 28 s 1.08±0.15 μM 1.08±0.15 μM 100
POPG 7.3 s 0.85±0.15 μM 0.85±0.15 μM 100
POPS 12.4 s 1.19±0.15 μM 1.19±0.15 μM 100
POPC:POPG (3:1) 18.2 s 0.35±0.04 μM 0.35±0.04 μM 100
POPC:POPS(3:1) 22.7 s 0.45±0.04 μM 0.45±0.04 μM 100
POPC:Cholesterol (3:2) 173 s 0.9±0.15 μM 1.7±0.2 μM 85
POPG:Cholesterol (3:2) 87 s 0.25±0.04 μM 0.26±0.04 μM 78
POPS:Cholesterol (3:2) 93 s 0.46±0.04 μM 1.13±0.15 μM 62
*Indicates that all time constant values carry a 5% error.
•Values carry a standard error of approximately 5%.
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membranes. A similar, but less pronounced effect of cholesterol
in slowing the kinetics of dye release from lipid vesicles is also
observed with anionic phospholipid LUVs (see Table 2). Finally,
our overall analyses indicate that the kinetics of GS14dK4-
induced dye release from the various LUVs studied increase in
the following order POPC/Chol bbPOPS/CholbPOPG/
CholbbPOPCbPOPC/POPSbPOPG/POPCbPOPSbPOPG.
This aspect of the fluorescent dye leakage data is thus
qualitatively compatible with the results of our ITC studies of
GS14dK4 binding to such vesicles, in that the kinetics of dye
release increases in parallel with the affinity and extent of
GS14dK4 binding (see ref. [26] and Table 1).
The overall amount of GS14dK4-induced dye leakage from
the LUVs was also examined as a function of lipid composition
and of the total peptide concentration in the aqueous buffer, and
the results of such studies are summarized in Table 2 and Figs.
2 and 3. For the single-component LUVs examined, plots of
percentage GS14dK4-induced dye leakage as a function of
peptide concentration described a sigmoidal curve on a semi-
log scale (see Fig. 2). There was little calcein release observed
at low peptide concentrations, indicating that there is a
threshold peptide concentration required for calcein release,
although the threshold concentrations differed among the
different vesicles. However, GS14dK4-induced dye leakage
from both zwitterionic and anionic LUVs was comparable over
the concentration range examined and, with all these single-
component LUVs, essentially complete leakage of the dye was
observed at high peptide concentrations. Also, the peptide
concentrations needed for 50% dye release (LD50) were all
clustered near 1.0±0.2 μM for all single-component LUVs
tested, regardless of whether they were composed of
zwitterionic (POPC) or anionic (POPG or POPS) phospholi-
pids (see Table 2). From these observations, it appears that total
GS14dK4-induced dye release from the single-component
LUVs is not strongly dependent of the surface charge densities
or phospholipid polar headgroup structures of the vesicles. This
conclusion contrasts sharply with the binding data derived from
the ITC measurements ([26] and Table 1), where the Kc values
for GS14dK4 binding to POPC LUVs are about 1000-fold
higher, and the Bmax values about 30-fold lower, for POPC as
compared to POPG or POPS vesicles, indicating a muchstronger and more extensive binding to anionic as compared to
zwitterionic phospholipid bilayers.
An examination of the peptide-induced dye release from
LUVs composed of the zwitterionic-anionic lipid mixtures,
POPC:POPG (3:1) and POPC:POPS (3:1), as a function of
peptide concentration indicates that the shapes of these release
profiles are similar to those of the single component LUVs, and
that the total amount of dye released at high peptide concen-
trations also approaches 100% (see Fig. 2). However, the curves
are shifted to the left, indicating that smaller amounts of the
peptide are required for dye leakage when compared to the
single-component LUVs. With these LUVs, the LD50 values for
dye leakage are clustered near 0.4±0.08 μM, values some 60%
lower than those obtained for single-component LUVs, indicat-
ing that the zwitterionic–anionic lipid mixtures are actually
more sensitive to GS14dK4-induced permeabilization than are
the single-component LUVs, including those composed entirely
of anionic lipids (see Fig. 2 and Table 2). This observation also
contrasts sharply with the results of our ITC studies, which
indicate that Kc and Bmax values for GS14dK4 binding to the
two-component POPC:POPG and POPG:POPG vesicles are
considerably lower (∼100-fold and 50% lower, respectively)
Fig. 3. GS14dK4-induced calcein leakage from cholesterol-free and cholesterol-containing lipid vesicles. Leakage data are presented as a function of peptide
concentration after incubation for 30 min at 25 °C. POPC—□—; POPC:Cholesterol (3:2)—▪—; POPG—○—; POPG:Cholesterol (3:2)—•—; POPS—△—;
POPS:Cholesterol(3:2) —▴—.
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vesicles (POPG or POPS) (see Table 1). The molecular basis of
this observation is currently unknown. However, it is possible
that the greater sensitivity of the binary zwitterionic–anionic
phospholipid LUVs to GS14dK4-induced dye leakage is the
result of peptide-induced domain formation caused by the
preferential binding of GS14dK4 to the anionic phospholipid
component which, in turn, could induce increased dye leakage at
the domain boundaries.
Illustrated in Fig. 3 are plots of the GS14dK4-induced calcein
leakage from cholesterol-rich POPC, POPG and POPS LUVs as
a function of peptide concentration. The overall shapes of these
dye-release curves differ significantly from those exhibited by
the corresponding cholesterol-free LUVs. When compared with
the latter, significantly larger amounts of dye are released in the
lower range of peptide concentrations and the total amount of
dye released at high peptide concentration is significantly lower
than the maximal value attainable upon addition of Triton-X 100
(see Fig. 3 and Table 2). One should note, however, that because
of the differences in the overall shapes of these curves, and in
particular the fact that the percentage of dye leakage at high
peptide concentrations is always significantly lower than 100%
(i.e., that released by Triton X-100), the sensitivity of any of
these cholesterol-rich LUVs to GS14dK4-induced leakage is not
fully captured by a single apparent LD50 value. Thus, for these
model membrane systems, we have reported the total amount of
peptide-inducible dye release and two apparent LD50 values,
reflecting the peptide concentrations required for half-maximal
dye release relative to the maximal peptide-inducible dye release
and the peptide concentrations required for half-maximal dyerelease relative to the total Triton X-100 releasable dye, respec-
tively (see Table 2). The results indicate that membrane cho-
lesterol generally suppresses the maximum amount of peptide-
inducible calcein leakage from such vesicles, and that the
magnitude of this effect varies with the nature of the phos-
pholipid component of the vesicle, being most noticeable with
POPS: cholesterol LUVs (see Fig. 3 and Table 2). This ob-
servation is qualitatively compatible with the results of the ITC
experiments (see Table 1). However, the same is not true of the
apparent LD50 values obtained. When examined relative to the
maximal peptide-inducible dye release, the apparent LD50
values are either comparable to (POPC:cholesterol) or smaller
than (POPG:cholesterol and POPS:cholesterol) those observed
with the corresponding cholesterol-free LUVs (see Table 2).
Moreover, when examined relative to the Triton X-100 inducible
dye release, the apparent LD50 values are either smaller than
(POPG:cholesterol), comparable to (POPS:cholesterol), or
slightly higher than (POPC:cholesterol) those obtained with
the corresponding cholesterol-free LUVs examined ( see Table
2). Overall, the apparent LD50 values obtained indicate that the
cholesterol-rich LUVs are considerable more sensitive to
GS14dK4-induced dye release than would be predicted from
the magnitudes of the Kc and Bmax values for GS14dK4 binding
to the same vesicles, where the incorporation of cholesterol into
POPG and POPS LUVs results in about a 10–100-fold reduction
in Kc values and a 50–60 fold decrease in Bmax values (see Table
1). Thus, although the ITC results are in qualitative agreement
with the dye leakage results as regards the total amount of
peptide-inducible dye release, the effect of cholesterol on dye
leakage is clearly much less than would be predicted by the ITC
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and extent by cholesterol incorporation than reflected in the
membrane disruption assay. Indeed, our observation of consi-
derable (∼80%) leakage from the cholesterol-rich POPC LUVs
at GS14dK4 concentrations near 10 μM is quite surprising when
viewed against the fact that GS14dK4 exhibits essentially no
hemolytic activity at concentrations below 60 μM [28], the fact
that ITC detects no measurable GS14dK4 binding to such
vesicles (see [26] and Table 1), and FTIR spectroscopic evidence
of poor GS14dK4 partitioning into cholesterol-rich PC bilayers
[24].
In most studies of peptide-induced fluorescent dye leakage
from lipid vesicles, the results are presented as plots of the
amount of dye released as a function of the total peptide
concentration, as was done in these studies (see Figs. 2 and 3).
However, such plots may not be particularly informative
because they do not actually correlate the extent of dye leakage
with the amount of peptide actually bound to the lipid vesicles,
and as noted in our previous ITC studies [26,27], the binding
affinities of such peptides and the amounts of peptide bound per
mole of phospholipid varies considerably with the lipid
composition of the LUV studied [26,27]. Thus, in order to
compare the potential of GS14dK4 to enhance membrane
permeability on a “per mole bound” basis, the percentage dye
leakage was plotted as a function of the fraction of bound
peptide per mole of total lipid in Fig. 4. This figure suggests that
for a given amount of bound peptide, GS14dK4 is actually more
efficient at permeabilizing neutral POPC membranes than
mixed POPC/anionic LUVs which, on a per mole bound basis,
are themselves more susceptible to GS14dK4-induced permea-
bilization than are LUVs composed of pure anionic membranes.
In the case of the cholesterol-rich anionic vesicles, they are
more susceptible to GS14dK4-induced permeabilization on a
per mole bound basis than the other vesicles at low peptide
concentrations, but considerably less so in the higher range of
peptide concentrations (see Fig. 4). Undoubtedly, the latterFig. 4. Relationship between calcein leakage and the molar ratio of bound
GS14dK4 per lipid, Bmax, as calculated by combining the binding isotherms
with the results of the dye release experiments. POPC □; POPG ○; POPS △;
POPC:POPS (3:1)▴; POPC:POPG (3:1)•; POPG:Cholesterol (3:2) +; POPS:
Cholesterol (3:2) ⁎.reflects the fact that these LUVs are not completely permea-
bilized at high concentrations of GS14dK4 (see Fig. 3). Finally,
we note that although not plotted on this scale, the cholesterol-
rich POPC vesicles would actually be the most sensitive of the
LUVs to GS14dK4-induced permeabilization on a per mole
bound basis, because there was no measurable GS14dK4
binding to these vesicles resolved in our ITC measurements
[26]. The results displayed in Fig. 4 seem inconsistent with the
conventional understanding of the effects of membrane surface
charge and membrane cholesterol levels on the permeabilization
of lipid vesicles by GS14dK4 and other AMPs. The implications
of these and other aspects of the data presented here are
explored in Discussion.
4. Discussion
In examining the results of the dye leakage assays, it is clear
that the LUVs studied formed three main groups with respect
to peptide-induced vesicle permeabilization. The first group,
the single-component lipid vesicles, have LD50 values near
1 μM and in these cases GS14dK4 is capable of inducing
∼100% dye leakage. The second group, consisting of
zwitterionic-anionic, two component lipid mixtures, exhibits
relatively smaller LD50 values (∼0.4 μM), and in these LUVs,
the peptide molecule is again capable of inducing full calcein
leakage. The third group, the cholesterol-containing anionic
phospholipid, two-component LUVs, exhibit similar or smaller
LD50 values but the relative amount of calcein released is
significantly lower than that released from the corresponding
cholesterol-free systems. These observations support the
following main conclusions. First, it is clear that there is little,
if any, correlation between either the binding affinity (Kc) or
extent of binding (Bmax) of GS14dK4 to the various
phospholipid bilayers studied (as measured by ITC) and the
peptide concentrations required to induce 50% dye leakage (as
measured by standard fluorescence dye leakage assays) from
lipid vesicles of identical composition. This is most apparent
with the cholesterol-rich PC vesicles from which significant
peptide-induced dye leakage was observed, despite the fact
that ITC indicates weak GS14dK4 binding to such vesicles.
Second, the kinetics of dye release from the LUVs, as reflected
in the time constants for the later stages of the dye release
process, are qualitatively but not quantitatively compatible
with the ITC-determined, lipid composition-induces changes in
affinity and extent of GS14dK4 binding to vesicles of the same
lipid compositions. Third, the affinity and extent of GS14dK4
binding to LUVs of varying phospholipid composition, as
measured by ITC, correlates much better with the relative in
vivo antimicrobial and hemolytic activities of this peptide [20–
23] than do the LD50 values for dye leakage from phospholipid
vesicles designed to mimic the lipid and cholesterol composi-
tion of bacterial and erythrocyte membranes. We comment on
these findings in more detail below.
The question arises as to whether the lack of correlation
between the strength and extent of binding to, and the ability to
disrupt and permeabilize, phospholipid bilayers observed in the
present study is peculiar to GS14dK4 or whether this is a more
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membranes. Althoughwe have not collected dye leakage data on
as large a number of LUVs composed of different phospholipids
for GS or GS10 as we have for GS14dK4, it nevertheless appears
that a similar lack of correlation between these two parameters
occurs in these peptides as well. For example, although GS itself
binds about 10-fold more tightly and several-fold more ex-
tensively to POPG and POPC/POPG (3:1) than to POPC LUVs
[27], this peptide is about 10-fold more potent at inducing
calcein dye leakage from POPC than from POPE/POPG (7:3)
LUVs [29]. Moreover, even greater differences between the
strength and extent of membrane binding and membrane
permeabilization [29] are observed for GS10 in comparison to
GS, although the GS10 differences are less than observed for
GS14dK4 in the present study. In addition, it has been reported
that the AMP PGLa, a member of the magainin family, binds
about 50-fold more tightly to POPC/POPG (3:1) than to POPC
vesicles, yet is about 3-fold less potent at releasing dye from the
POPC/POPG vesicles when compared on a per mole of peptide
bound basis [30]. Although we are not aware of any comparative
studies of phospholipid vesicle binding and vesicle permeation
with other antimicrobial peptides, we conclude that the observed
disconnection between phospholipid bilayer binding and
disruption by AMPs may be a general phenomenon, since it
has been observed in GS and in several cyclic, β-sheet peptide
analogs thereof by us, and in a linear, amphiphilic, α-helix-
forming peptide of the magainin family by others.
The molecular basis of the relatively greater potency of
antimicrobial peptides for permeabilizing zwitterionic POPC in
preference to anionic POPG or POPS vesicles, although binding
much more weakly to the former, is currently unknown. One
possibility is that GS and its analogs may penetrate more deeply
into zwitterionic than anionic phospholipid bilayers and may
thus disrupt membrane organization to a greater extent in the
former. However, our previous FTIR [15,24] and fluorescence
[29] studies indicate that GS and its analogs partition into a more
polar environment upon interaction with zwitterionic lipids than
is the case with anionic phospholipids, suggesting that these
peptides penetrate less deeply into the zwitterionic lipid bilayers.
Another possibility is that the binding of GS and GS14dK4,
which bear 2 or 4 positive charges, respectively, would impart a
net positive charge to zwitterionic POPC LUVs while pro-
gressively neutralizing the high negative charge on anionic
POPG or POPS vesicles. Thus, the binding of cationic peptides
to zwitterionic phospholipid vesicles would be expected to lead
to an accumulation of positive charge on the bilayer surface, and
thus weaken phospholipid packing somewhat, whereas their
binding to anionic phospholipid vesicles would be expected to
neutralize the negative charge on the bilayer surface, and thus to
increase phospholipid packing considerably, thereby stabilizing
the vesicle permeability barrier. As well, since the fluorescence
dye calcein is negatively charged, its concentration near the
inside surface of negatively charged LUVs may be reduced by
charge repulsion effects, so that dye leakage is also reduced
compared to zwitterionic LUVs. It should also be noted that dye
leakage studies are conducted at much higher protein/lipid molar
ratios than are ITC studies. However, given the disparitybetween the extents of GS14dK4 binding to the zwitterionic and
anionic vesicles, and the disproportionally small difference
between the LD50 values measured for GS14dK4-induced dye
leakage, it is apparent that a significant fraction of the peptide
bound to the anionic lipid vesicles is not directly involved in
lysis. Thus, it is also possible that most of the GS14dK4 bound to
the anionic lipid vesicles are actually interacting with the
negatively charged phosphate groups on the bilayer surface and
are not directly involved in the processes leading to membrane
permeation and/or lysis.
There are currently two major models for the mechanism of
action of AMPs on lipid bilayer membranes, both based pri-
marily on studies of linear, amphiphilic, α-helical peptides (see
[32]). In the “carpet model”, the amphiphilic AMP molecules
bind to the surface of the phospholipid bilayer, parallel to the
membrane plane, with the cationic amino acid residues under-
going primarily electrostatic interactions with the negatively
charged phosphatemoieties of the phospholipid polar headgroup
and the side chains of the hydrophobic amino acids penetrating
partly into the bilayer hydrocarbon core. When the outer surface
of the lipid bilayer is essentially saturated with bound peptide
molecules, the bilayer becomes destabilized and the peptide then
has access to the inner surface of the bilayer. When both surfaces
are covered with peptide, the membrane essentially disintegrates
into peptide-coatedmembrane fragments or peptide–lipid mixed
micelles, such that the bilayer is essentially solubilized by the
AMP molecules. In the “pore model”, the amphiphilic peptides
again bind initially to the bilayer surface in an orientation
parallel to the membrane plane, but upon reaching a critical
concentration, some of the peptide undergoes aggregation and a
90° reorientation to form water-filled pores which traverse the
lipid bilayer. These pores may be of the barrel-stave type, where
the inside surface of the pores are lined with the polar portions of
the peptide molecules, or of the toroidal type, where the lipid
polar headgroups form the water-filled interior of the pore.
AMPs which form barrel stave pores are characterized by
inducing a negative curvature in the host phospholipid bilayer in
order to accommodate the pore, while peptides which form
toroidal pores induce a positive curvature in the bilayer, in order
to allow the lipid polar headgroups to reorient to form the pore
interior [31].
The question arises as to whether the GS14dK4 LUVs
binding and dye leakage data supports one or more of the models
discussed above, considering that GS and its analogs are smaller,
cyclic β-sheet structures and not the larger, linear, α-helical
structures characteristic of the AMPs on which these models are
largely based. Certainly one conclusion which can be firmly
drawn is that GS14dK4 does not disrupt zwitterionic POPC
vesicles via a carpet mechanism. This follows from the fact that
substantial dye leakage occurs at very low GS14dK4 concentra-
tions where less than one molecule of peptide is bound per 100
phospholipid molecules (see Fig. 4), far less than the peptide–
lipid ratio which would be required to saturate the bilayer
surfaces. A similar argument probably applies to a lesser degree
to the POPC/POPG (3:1) and POPC/POPS (3:1) vesicles, but not
necessarily to the POPG vesicles. Therefore, the carpet model
remains a possibility for vesicles composed entirely of anionic
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dominantly of zwitterionic phospholipids. However, the barrel
stave model remains a formal possibility, since GS and its
analogs induce negative bilayer curvature [13,14] and since the
critical concentration at which these peptide molecules are
likely to aggregate and reorient in the membrane to form a
peptide-lined pore is not known. However, the data in Fig. 5
require that this critical concentration must vary by more than
10-fold, depending on vesicle surface charge and polar head-
group structure. Moreover, the idea that cyclic, disk-shaped
peptides such as GS and its analogs, whose dimensions are
much smaller than the thickness of the phospholipid bilayer,
could form peptide-lined aqueous pores in the manner of the
much longer α-helical antimicrobial peptides seems proble-
matic, particularly in view of the highly repulsive electrostatic
interactions which would be expected to occur between the
positively charged Orn or Lys residue side chains which would
presumably line the interior of such a pore. Finally, the toroidal
pore mechanism also seems unlikely in view of the fact that GS
and its analogs strongly induce negative, not positive, curvature
in their host lipid bilayers.
As we [1] and others [32] have noted, there are other
possibilities for at least the transient disruption of the integrity of
the phospholipid bilayer membrane by AMPs which do not
involve any of the mechanisms discussed above. In particular, the
well-known ability of GS and its analogs to thin and disorder
phospholipid bilayers discussed earlier may result in transient
defects or “pores” in the membrane bilayer of sufficient size to
pass even relatively large, charged molecules like fluorescence
dyes, without the gross structure of the bilayer being compromised
over large distances and time scales, particularly at lower peptide
concentrations. Moreover, at higher but still physiologically
relevant peptide concentrations, GS and its analogs can induce the
actual formation of inverted cubic phases in phospholipid model
membranes of appropriate compositions, sometimes at physiolo-
gically relevant temperatures. Such a local disruption of bilayer
structure would also compromise the integrity of the permeability
barrier of the model membrane by a mechanism other than that
postulated in either the carpet or pore models of AMP action. In
fact, all things considered, our present and previous results are
probably more compatible with these latter alternative mechan-
isms of antimicrobial peptide action than with the conventional
mechanisms derived from data on linear, α-helical antimicrobial
peptides. Moreover, as we [1] and others [32] have argued, the
primary mechanism of action of AMPs may well vary with
peptide concentration and with the phospholipid or cholesterol
composition of the lipid bilayer, as appears to be the case here.
Finally, as noted above, the affinity and extent of GS14dK4
binding to LUVs of different phospholipid and cholesterol
compositions correlatesmuch better with the absolute and relative
antimicrobial and hemolytic activities of GS and several of its
designed analogs [20–22] than do the LD50 values determined in
the standard dye leakage assay performed on the same vesicles.
This seems a surprising observation, since there is strong evidence
that GS and its analogues kill bacterial cells and lyse erythrocytes
primarily by destroying the functional integrity of the phospho-
lipid bilayers of their membranes [1,9–11]. Indeed, one wouldhave expected that the dye leakage assay, supposedly being a
fairly direct measure of the disruption of phospholipid bilayer
integrity, would have correlated best with the in vivo activities of
these AMPs, but this is clearly not the case. Thus, at the very
least, this observation suggests that conventional dye leakage
assays performed on phospholipid LUVs are failing to capture an
important feature of the in vivo action of GS and other AMPs on
bacterial and erythrocyte cell membranes. It may also imply that
the binding of these peptides to live cells is associated with one or
more sub-lethal effects which can significantly affect cell growth
and proliferation without directly causing cell lysis. Evidently,
such effects would be reflected in the MIC and LD50 values
returned by antimicrobial growth inhibition assays, but will not be
captured by conventional assays of dye leakage from lipid bilayer
model membranes of the type performed in these and numerous
other studies. Clearly, more experimental work is required to
resolve this apparent discrepancy, both with regard to explaining
the poor correlation between dye leakage potency and in vivo
antimicrobial and hemolytic activities, and to explaining the
relatively good correlation between the affinity and extent of
peptide binding and the peptide in vivo activity. Nevertheless, our
study strongly suggests that dye leakage assays alone should not
be relied upon as valid predictors of antimicrobial and hemolytic
activities in vivo.
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